These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25448321)

  • 41. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis (as of 02. 07. 2014)].
    Heiligenhaus A; Bertram B; Heinz C; Krause L; Pleyer U; Roider J; Sauer S; Thurau S
    Klin Monbl Augenheilkd; 2014 Sep; 231(9):929-36. PubMed ID: 25181508
    [No Abstract]   [Full Text] [Related]  

  • 42. [Topical and systemic corticosteroid therapy for uveitis in childhood].
    Thurau SR; Frosch M; Zierhut M; Gümbel H; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):516-9. PubMed ID: 17594623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraocular corticosteroids for posterior segment disease: 2012 update.
    Kiernan DF; Mieler WF
    Expert Opin Pharmacother; 2012 Aug; 13(12):1679-94. PubMed ID: 22783878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
    Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of steroids and immunosuppressive drugs in the management of posterior uveitis.
    Lightman S
    Eye (Lond); 1991; 5 ( Pt 3)():294-8. PubMed ID: 1955050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ligneous conjunctivitis].
    Bauer M; Koinzer S; Oschlies I; Claviez A; Tiede K; Roider J; Nölle B
    Ophthalmologe; 2016 May; 113(5):416-9. PubMed ID: 26142234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review: uveitis and immunosuppressive drugs.
    Kulkarni P
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):181-7. PubMed ID: 11324985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression for the Uveitides.
    Jabs DA
    Ophthalmology; 2018 Feb; 125(2):193-202. PubMed ID: 28942074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uveitis for the non-ophthalmologist.
    Burkholder BM; Jabs DA
    BMJ; 2021 Feb; 372():m4979. PubMed ID: 33536186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [TNFalpha inhibitors in the treatment of uveitis].
    Greiner K; Plskova J
    Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central serous chorioretinopathy, corticosteroids, and uveitis.
    Khairallah M; Kahloun R; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The clinical feature, diagnosis and treatment of uveitis associated with juvenile chronic arthritis].
    Zhang Z; Yang PZ; Zhou HY; Yu Q; Huang XK; Li B
    Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):346-9. PubMed ID: 15924698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
    Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intravitreal injection of triamcinolone acetonide in non infectious uveitis].
    Benítez Del Castillo Sánchez JM; García Sánchez J
    Arch Soc Esp Oftalmol; 2001 Nov; 76(11):661-4. PubMed ID: 11715104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sarcoid uveitis: Diagnostic and therapeutic update].
    Varron L; Abad S; Kodjikian L; Sève P
    Rev Med Interne; 2011 Feb; 32(2):86-92. PubMed ID: 20970226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Uveitic cystoid macular edema: intravitreal triamcinolone].
    Feucht M; Sturm V; Weissmann J; Richard G; Pressmar S
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):62-5. PubMed ID: 17260323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Central nervous system demyelinating disease-associated uveitis].
    Llorenç V; Rey A; Mesquida M; Pelegrín L; Adán A
    Arch Soc Esp Oftalmol; 2012 Oct; 87(10):324-9. PubMed ID: 23021230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.